Influenza vaccination and risk of community-acquired pneumonia

The Lancet

Volumn 372, Issue 9656, 2008, Pages 2112-

  Thijs, Carel ^a   Knottnerus, André ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

COMMUNITY ACQUIRED PNEUMONIA; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LETTER; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

EID: 57649237732     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61921-2     Document Type: Letter

References (3)

1. Jackson M.L., Nelson J.C., Weiss N.S., Neuzil K.M., Barlow W., and Jackson L.A. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 372 (2008) 398-405
2. Govaert T., Thijs C., Masurel N., Sprenger M.J.W., Dinant G.J., and Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 272 (1994) 1661-1665
3. Thijs C., Beyer W., Govaert T., Sprenger M.J.W., Dinant G.J., and Knottnerus A. Mortality benefit of influenza vaccination in elderly people. Lancet Infect Dis 8 (2008) 460-461